Tekla Healthcare Investors (HQH)

$20

-0.14 (-0.70%)
Rating:
Recommendation:
-
Symbol HQH
Price $20
Beta 0.836
Volume Avg. 0.10M
Market Cap 926.878M
Shares () -
52 Week Range 17.42-28.05
1y Target Est -
DCF Unlevered HQH DCF ->
DCF Levered HQH LDCF ->
ROE 3.45% Neutral
ROA 3.64% Neutral
Operating Margin -
Debt / Equity 1.26% Neutral
P/E -
P/B 0.85 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest HQH news


Financial Services
Asset Management
New York Stock Exchange

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.